Automate processing, release predictive insight
Forward-thinking pharmaceutical companies are doing more than simply reporting adverse events. With digital technologies they're harnessing the power of prediction to protect what really matters: patient health.
Companies spend billions of dollars on pharmacovigilance (PV) every year, yet adverse drug reactions remain a major, preventable cause of death. Our suite of technologies uses AI, natural language understanding, computer vision, and more to streamline case processing by 50%, increase the speed and sensitivity of signal detection, and unlock predictive insights.
